BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18698224)

  • 1. Vascular endothelial growth factor, left ventricular dysfunction and mortality in hemodialysis patients.
    Mallamaci F; Benedetto FA; Tripepi G; Cutrupi S; Pizzini P; Stancanelli B; Seminara G; Bonanno G; Rapisarda F; Fatuzzo P; Malatino LS; Zoccali C
    J Hypertens; 2008 Sep; 26(9):1875-82. PubMed ID: 18698224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients.
    Mallamaci F; Zoccali C; Parlongo S; Tripepi G; Benedetto FA; Cutrupi S; Bonanno G; Fatuzzo P; Rapisarda F; Seminara G; Stancanelli B; Bellanuova I; Cataliotti A; Malatino LS
    Am J Kidney Dis; 2002 Jul; 40(1):68-75. PubMed ID: 12087563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial dysfunction in patients with kidney failure and vascular risk factors: acute effects of hemodialysis.
    Migliacci R; Falcinelli F; Imperiali P; Floridi A; Nenci GG; Gresele P
    Ital Heart J; 2004 May; 5(5):371-7. PubMed ID: 15185901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 is a predictor of mortality in stable hemodialysis patients.
    Hasuike Y; Nonoguchi H; Ito K; Naka M; Kitamura R; Nanami M; Tokuyama M; Kida A; Otaki Y; Kuragano T; Nakanishi T
    Am J Nephrol; 2009; 30(4):389-98. PubMed ID: 19690405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of visfatin levels to inflammatory cytokines and left ventricular hypertrophy in hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Erten Y; Ebinç FA; Ebinç H; Paşaoğlu H; Demirtaş C; Taçoy G; Koç E; Derici U; Reis KA; Bali M; Arinsoy T; Sindel S
    Ren Fail; 2008; 30(6):617-23. PubMed ID: 18661412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble e-selectin is an inverse and independent predictor of left ventricular wall thickness in end-stage renal disease patients.
    Stancanelli B; Malatino LS; Cataliotti A; Bellanuova I; Mallamaci F; Tripepi G; Benedetto FA; Leonardis D; Fatuzzo P; Rapisarda F; Zoccali C
    Nephron Clin Pract; 2010; 114(1):c74-80. PubMed ID: 19851079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new systolic parameter defined as the ratio of brachial pre-ejection period to brachial ejection time predicts overall and cardiovascular mortality in hemodialysis patients.
    Chen SC; Chang JM; Tsai JC; Hsu PC; Lin TH; Su HM; Voon WC; Hwang SJ; Chen HC
    Hypertens Res; 2010 May; 33(5):492-8. PubMed ID: 20203683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible involvement of TNF-alpha in left ventricular remodeling in hemodialysis patients.
    Nishimura M; Hashimoto T; Kobayashi H; Fukukda T; Okino K; Yamamoto N; Nakamura N; Yoshikawa T; Takahashi H; Ono T
    J Nephrol; 2003; 16(5):641-9. PubMed ID: 14733409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephrol Dial Transplant; 2009 Sep; 24(9):2792-6. PubMed ID: 19395730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodialysis-induced left ventricular dysfunction is associated with an increase in ventricular arrhythmias.
    Burton JO; Korsheed S; Grundy BJ; McIntyre CW
    Ren Fail; 2008; 30(7):701-9. PubMed ID: 18704819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left-ventricular diastolic dysfunction as a risk factor for dialytic hypotension.
    Rostoker G; Griuncelli M; Loridon C; Benmaadi A; Illouz E
    Cardiology; 2009; 114(2):142-9. PubMed ID: 19521079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasting glucose levels in predicting 1-year all-cause mortality in patients who do not have diabetes and are on maintenance hemodialysis.
    Lin-Tan DT; Lin JL; Wang LH; Wang LM; Huang LM; Liu L; Huang JY; Huang YL
    J Am Soc Nephrol; 2007 Aug; 18(8):2385-91. PubMed ID: 17599971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cohort study of subjective global assessment and mortality in Taiwanese hemodialysis patients.
    Yang FL; Lee RP; Wang CH; Fang TC; Hsu BG
    Ren Fail; 2007; 29(8):997-1001. PubMed ID: 18067047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition.
    de Mutsert R; Grootendorst DC; Indemans F; Boeschoten EW; Krediet RT; Dekker FW;
    J Ren Nutr; 2009 Mar; 19(2):127-35. PubMed ID: 19218039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failure.
    Lamblin N; Susen S; Dagorn J; Mouquet F; Jude B; Van Belle E; Bauters C; de Groote P
    Am Heart J; 2005 Jul; 150(1):137-43. PubMed ID: 16084160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients.
    Carrero JJ; Chmielewski M; Axelsson J; Snaedal S; Heimbürger O; Bárány P; Suliman ME; Lindholm B; Stenvinkel P; Qureshi AR
    Clin Nutr; 2008 Aug; 27(4):557-64. PubMed ID: 18538898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure and cardiovascular mortality in dialysis patients with left ventricular systolic dysfunction.
    Losito A; Del Vecchio L; Del Rosso G; Malandra R;
    Am J Hypertens; 2014 Mar; 27(3):401-8. PubMed ID: 24108864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Left ventricular hypertrophy in patients on hemodialysis: importance of anemia].
    Stojimirović B; Petrović D; Obrenović R
    Med Pregl; 2007; 60 Suppl 2():155-9. PubMed ID: 18928184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating vascular endothelial growth factor (VEGF) and its soluble receptor 1 (sVEGFR-1) are associated with inflammation and mortality in incident dialysis patients.
    Yuan J; Guo Q; Qureshi AR; Anderstam B; Eriksson M; Heimbürger O; Bárány P; Stenvinkel P; Lindholm B
    Nephrol Dial Transplant; 2013 Sep; 28(9):2356-63. PubMed ID: 23828162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of transforming growth factor-beta(1) with tumour necrosis factor-alpha and endothelial activation in patients with stable renal transplantation.
    Palermo A; Mulè G; Vadalà A; Vaccaro F; Guarneri M; Arsena R; Briolotta C; Cerasola G; Cottone S
    Nephrology (Carlton); 2008 Apr; 13(2):164-70. PubMed ID: 18275506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.